CHRONIC myelogenous leukemia (CML) is the only malignancy in which a specific and consistent chromosome abnormality has been consistently documented.1 This cytogenetic abnormality, designated the Philadelphia (Ph') chromosome, appears to be limited to CML2-5 or closely related variants.6 Therefore, its demonstration may be regarded as at least presumptive evidence for this disease.
Another characteristic of CML is the depressed level of the leukocyte alkaline phosphatase activity (LAP).7 An elevated LAP in a myeloproliferative disorder has been generally assumed to exclude a diagnosis of CML.8 Recently, however, both Rosen and Teplitz9 and Heath and Moloney10 have reported elevated LAP levels in patients with Ph' positive CML coexisting with a second disorder. These two reports suggest that elevated enzyme values may occur in CML if the leukemic process is accompanied by another disease. The present paper describes the third case of an elevated LAP in a Ph' positive CML in the presence
Winkelstein A, Goldberg LS, Tishkoff GH, Sparkes RS. Leukocyte Alkaline Phosphatase and the Philadelphia Chromosome. Arch Intern Med. 1967;119(3):291–296. doi:10.1001/archinte.1967.00290210123012
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: